drugset / Trial / NCT00078247
Anti-HIV Drugs for Ugandan Patients With HIV and Tuberculosis
Phase 3
Completed
350 enrolled
National Institute of Allergy and Infectious Diseases (NIAID)
Makerere University · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
This study is designed to determine whether 6 months of anti-HIV drugs given along with tuberculosis treatment will delay the onset of AIDS in HIV infected African patients.
Timeline
- Start
- 2004-10
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Abacavir | Other / unclassified | 300 mg | Oral |
| Subject | Lamivudine | Other / unclassified | 300 mg | Oral |
| Subject | Zidovudine | Small molecule | 300 mg | Oral |